Immunodiagnosis and Immunotherapy of Patients with Alzheimer’s Syndrome
暂无分享,去创建一个
[1] C. Broeckhoven,et al. Failure of familial Alzheimer's disease to segregate with the A4-amyloid gene in several European families , 1987, Nature.
[2] J. Haines,et al. The genetic defect in familial Alzheimer's disease is not tightly linked to the amyloid β-protein gene , 1987, Nature.
[3] R. Benner,et al. Deterioration of cellular immunity during aging. The relationship between age-dependent impairment of delayed-type hypersensitivity reactivity, interleukin-2 production capacity, and frequency of Thy-1+,Lyt-2- cells in C57BL/Ka and CBA/Rij mice. , 1987, Cellular immunology.
[4] H. Fudenberg,et al. Generation of phenotypically distinct macrophage-hepatoma hybrid clones. , 1987, Immunobiology.
[5] B. Cohen,et al. Platelet membrane fluidity in Alzheimer's disease and major depression. , 1987, The American journal of psychiatry.
[6] P. White,et al. Congenital adrenal hyperplasia. (First of two parts) , 1987 .
[7] M. Dąbrowski,et al. Immunologic and Clinical Evaluation of Multiple Sclerosis Patients Treated with Corticosteroids and/or Calf Thymic Hormones , 1987, Annals of the New York Academy of Sciences.
[8] F. R. Brown,et al. Immunologic dysfunction: simultaneous study of alzheimer's and older down's patients , 1987, Mechanisms of Ageing and Development.
[9] Fudenberg Hh,et al. Can blood immunocytes be used to study neuropsychiatric disorders , 1986 .
[10] A. Weetman,et al. The IgG subclass distribution of thyroid autoantibodies. , 1986, Immunology letters.
[11] G. Canonica,et al. Does normal lymphocyte DNA synthesis in response to PHA exclude cell-mediated immunodepression? , 1986, Clinical immunology and immunopathology.
[12] D. Gajdusek,et al. Antibodies to neurofilament protein in retinitis pigmentosa. , 1986, The Journal of clinical investigation.
[13] V. Singh,et al. Detection of brain autoantibodies in the serum of patients with Alzheimer's disease but not Down's syndrome. , 1986, Immunology letters.
[14] David M. A. Mann,et al. The neuropathology of Alzheimer's disease: A review with pathogenetic, aetiological and therapeutic considerations , 1985, Mechanisms of Ageing and Development.
[15] H. Wiśniewski,et al. Current Hypothesis of the Etiology and Pathogenesis of Senile Dementia of the Alzheimer Type , 1985 .
[16] G. Glenner. On causative theories in Alzheimer's disease. , 1985, Human pathology.
[17] D. Gajdusek,et al. The 200- and 150-kDa neurofilament proteins react with IgG autoantibodies from patients with kuru, Creutzfeldt-Jakob disease, and other neurologic diseases. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[18] E. Bandle,et al. 2-Pyrrolidinone and succinimide endogenously present in several mammalian species. , 1984, Life sciences.
[19] G. Zubenko. Dr. Zubenko Replies , 1984 .
[20] P. Arnaud,et al. Is Alzheimer's disease an immunological disorder? Observations and speculations. , 1984, Clinical immunology and immunopathology.
[21] W. Fierz,et al. Astrocytes present myelin basic protein to encephalitogenic T-cell lines , 1984, Nature.
[22] O. Beck. Distribution of virus antibody activity among human IgG subclasses. , 1981, Clinical and experimental immunology.
[23] M. Weksler. The Immune System and the Aging Process in Man 1 , 1980, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[24] S. Weitzman,et al. Correlation between serum IgG-2 concentrations and the antibody response to bacterial polysaccharide antigens. , 1980, The New England journal of medicine.
[25] V. Singh,et al. Increase of immunoglobulin G3 subclass is related to brain autoantibody in Alzheimer's disease but not in Down's syndrome. , 1989, Autoimmunity.
[26] S. Gammeltoft,et al. Acetylcholine receptor antibody in myasthenia gravis: predominance of IgG subclasses 1 and 3. , 1987, Clinical and experimental immunology.
[27] M. French. Immunoglobulins in Health and Disease , 1986, Immunology and Medicine Series.
[28] L. Hammarström,et al. Immunoglobulin Isotype Diversity and its Functional Significance , 1986 .
[29] V. Singh,et al. Immunopharmacological approach to the study of chronic brain disorders. , 1986, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques.
[30] R. Dawkins,et al. CHAPTER 22 – Autoimmune Diseases of Muscle: Myasthenia Gravis and Myositis* , 1985 .
[31] B. Arnason. CHAPTER 15 – Multiple Sclerosis, Allied Central Nervous System Diseases, and Immune-Mediated Neuropathies , 1985 .
[32] P. Arnaud,et al. Immune diagnosis of a subset of Alzheimer's disease with preliminary implications for immunotherapy. , 1984, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[33] A. Ugazio,et al. Down syndrome: a model of immunodeficiency. , 1983, Birth defects original article series.
[34] D. Segre,et al. Immunological aspects of aging , 1981 .
[35] Daniel P. Stites,et al. Basic and Clinical Immunology , 1976 .